193 related articles for article (PubMed ID: 33484165)
21. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.
Liu Y; Liu Z; Wei M; Hu M; Yue K; Bi R; Zhai S; Pi Z; Song F; Liu Z
Food Funct; 2019 Jan; 10(1):432-447. PubMed ID: 30623955
[TBL] [Abstract][Full Text] [Related]
23. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Kori M; Aydın B; Unal S; Arga KY; Kazan D
OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769
[TBL] [Abstract][Full Text] [Related]
24. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Cocaine Effect on Endogenous Metabolites of HepG2 Cells Using Targeted Metabolomics.
Krokos A; Deda O; Virgiliou C; Gika H; Raikos N; Aggelidou E; Kritis A; Theodoridis G
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361761
[TBL] [Abstract][Full Text] [Related]
26. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
Jones RS; Waldman AD
Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265
[TBL] [Abstract][Full Text] [Related]
27. Recent advances from metabolomics and lipidomics application in alzheimer's disease inspiring drug discovery.
Cuperlovic-Culf M; Badhwar A
Expert Opin Drug Discov; 2020 Mar; 15(3):319-331. PubMed ID: 31619081
[No Abstract] [Full Text] [Related]
28. Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an A
Yi M; Zhang C; Zhang Z; Yi P; Xu P; Huang J; Peng W
Oxid Med Cell Longev; 2020; 2020():5243453. PubMed ID: 32655770
[TBL] [Abstract][Full Text] [Related]
29. A metabolomic study based on accurate mass and isotopic fine structures by dual mode combined-FT-ICR-MS to explore the effects of Rhodiola crenulata extract on Alzheimer disease in rats.
Zhang X; Jiang X; Wang X; Zhao Y; Jia L; Chen F; Yin R; Han F
J Pharm Biomed Anal; 2019 Mar; 166():347-356. PubMed ID: 30690248
[TBL] [Abstract][Full Text] [Related]
30. Metabolic profiling of the effects of ginsenoside Re in an Alzheimer's disease mouse model.
Li J; Liu Y; Li W; Wang Z; Guo P; Li L; Li N
Behav Brain Res; 2018 Jan; 337():160-172. PubMed ID: 28927718
[TBL] [Abstract][Full Text] [Related]
31. High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice.
Li G; Zhang N; Geng F; Liu G; Liu B; Lei X; Li G; Chen X
Sci Rep; 2019 May; 9(1):7040. PubMed ID: 31065079
[TBL] [Abstract][Full Text] [Related]
32. Alterations in Peripheral Metabolites as Key Actors in Alzheimer's Disease.
Sheng C; Chu X; He Y; Ding Q; Jia S; Shi Q; Sun R; Song L; Du W; Liang Y; Chen N; Yang Y; Wang X
Curr Alzheimer Res; 2023; 20(6):379-393. PubMed ID: 37622711
[TBL] [Abstract][Full Text] [Related]
33. Alterations in metabolic pathways and networks in Alzheimer's disease.
Kaddurah-Daouk R; Zhu H; Sharma S; Bogdanov M; Rozen SG; Matson W; Oki NO; Motsinger-Reif AA; Churchill E; Lei Z; Appleby D; Kling MA; Trojanowski JQ; Doraiswamy PM; Arnold SE;
Transl Psychiatry; 2013 Apr; 3(4):e244. PubMed ID: 23571809
[TBL] [Abstract][Full Text] [Related]
34. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease.
Trushina E; Nemutlu E; Zhang S; Christensen T; Camp J; Mesa J; Siddiqui A; Tamura Y; Sesaki H; Wengenack TM; Dzeja PP; Poduslo JF
PLoS One; 2012; 7(2):e32737. PubMed ID: 22393443
[TBL] [Abstract][Full Text] [Related]
35. NMR-based metabolomics in Alzheimer's disease research: a review.
Vignoli A; Tenori L
Front Mol Biosci; 2023; 10():1308500. PubMed ID: 38099198
[TBL] [Abstract][Full Text] [Related]
36. Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer's Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls.
Jasbi P; Shi X; Chu P; Elliott N; Hudson H; Jones D; Serrano G; Chow B; Beach TG; Liu L; Jentarra G; Gu H
J Proteome Res; 2021 Sep; 20(9):4303-4317. PubMed ID: 34355917
[TBL] [Abstract][Full Text] [Related]
37. Metabolomics Provides Novel Insights into Epilepsy Diagnosis and Treatment: A Review.
Lai W; Du D; Chen L
Neurochem Res; 2022 Apr; 47(4):844-859. PubMed ID: 35067830
[TBL] [Abstract][Full Text] [Related]
38. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
[TBL] [Abstract][Full Text] [Related]
39. Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.
Xu XH; Huang Y; Wang G; Chen SD
Neurosci Bull; 2012 Oct; 28(5):641-8. PubMed ID: 23054640
[TBL] [Abstract][Full Text] [Related]
40. Application of Metabolomics to the Discovery of Biomarkers for Ischemic Stroke in the Murine Model: a Comparison with the Clinical Results.
Jia J; Zhang H; Liang X; Dai Y; Liu L; Tan K; Ma R; Luo J; Ding Y; Ke C
Mol Neurobiol; 2021 Dec; 58(12):6415-6426. PubMed ID: 34532786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
